Zorabi-DSR
Description_Effects
Zorabi-DSR is a dual-action formulation designed to effectively manage acid-related disorders of the stomach and esophagus. It combines Domperidone and Rabeprazole in a sustained-release form to provide prolonged and comprehensive relief from symptoms such as acidity, heartburn, indigestion, bloating, and gastroesophageal reflux disease (GERD). Rabeprazole, a proton pump inhibitor (PPI), works by reducing the production of gastric acid at its source in the stomach lining. This reduction in acid levels helps heal acid-related damage, prevent ulcers, and offer long-term symptom control. Domperidone, a prokinetic agent, complements Rabeprazole by enhancing gastrointestinal motility. It increases the movement of the stomach and intestines, helping food pass more efficiently through the digestive tract. This action reduces feelings of nausea, bloating, and fullness while supporting better gastric emptying. Zorabi-DSR’s sustained-release formulation ensures that the medication remains active in the body over an extended period, making it particularly useful for patients who require consistent control of gastric symptoms throughout the day. When taken regularly before meals as directed by a healthcare provider, it promotes effective relief, improved digestion, and a better quality of life for individuals suffering from chronic acid reflux and functional dyspepsia.
